Correlation Between Bolt Biotherapeutics and SAB Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Bolt Biotherapeutics and SAB Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bolt Biotherapeutics and SAB Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bolt Biotherapeutics and SAB Biotherapeutics, you can compare the effects of market volatilities on Bolt Biotherapeutics and SAB Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bolt Biotherapeutics with a short position of SAB Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bolt Biotherapeutics and SAB Biotherapeutics.
Diversification Opportunities for Bolt Biotherapeutics and SAB Biotherapeutics
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bolt and SAB is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Bolt Biotherapeutics and SAB Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SAB Biotherapeutics and Bolt Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bolt Biotherapeutics are associated (or correlated) with SAB Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SAB Biotherapeutics has no effect on the direction of Bolt Biotherapeutics i.e., Bolt Biotherapeutics and SAB Biotherapeutics go up and down completely randomly.
Pair Corralation between Bolt Biotherapeutics and SAB Biotherapeutics
Given the investment horizon of 90 days Bolt Biotherapeutics is expected to under-perform the SAB Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Bolt Biotherapeutics is 3.15 times less risky than SAB Biotherapeutics. The stock trades about -0.2 of its potential returns per unit of risk. The SAB Biotherapeutics is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 275.00 in SAB Biotherapeutics on August 24, 2024 and sell it today you would earn a total of 32.00 from holding SAB Biotherapeutics or generate 11.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bolt Biotherapeutics vs. SAB Biotherapeutics
Performance |
| Timeline |
| Bolt Biotherapeutics |
| SAB Biotherapeutics |
Bolt Biotherapeutics and SAB Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bolt Biotherapeutics and SAB Biotherapeutics
The main advantage of trading using opposite Bolt Biotherapeutics and SAB Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bolt Biotherapeutics position performs unexpectedly, SAB Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SAB Biotherapeutics will offset losses from the drop in SAB Biotherapeutics' long position.| Bolt Biotherapeutics vs. Lyra Therapeutics | Bolt Biotherapeutics vs. Hookipa Pharma | Bolt Biotherapeutics vs. Cingulate Warrants | Bolt Biotherapeutics vs. SAB Biotherapeutics |
| SAB Biotherapeutics vs. Processa Pharmaceuticals | SAB Biotherapeutics vs. Third Harmonic Bio | SAB Biotherapeutics vs. Cingulate Warrants | SAB Biotherapeutics vs. Anebulo Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |